About AVT
Browse Articles
Customer Services


Application of mass spectrometry to molecular surveillance of hepatitis B and C viral infections

Lilia M Ganova-Raeva, Zoya E Dimitrova, David S Campo, Yury Khudyakov

Corresponding author name: Lilia M Ganova-Raeva
Corresponding author e-mail: LGanova-Raeva@cdc.gov

Citation: Antiviral Therapy 2012; 17:1477-1482
doi: 10.3851/IMP2466

Date accepted: 13 June 2012
Date published online: 07 December 2012


Detection of genotypes and drug resistance mutations are important molecular tools assisting in clinical management of patients with chronic hepatitis B and C. Together with methods for assessment of genetic heterogeneity and relatedness of viral strains, they form the foundation of molecular surveillance. Currently, all these methods are based mainly on DNA sequencing followed by phylogenetic analysis. Mass spectrometry (MS) emerged recently as a rapid, cost-effective, reproducible and accurate alternative approach. MS-based molecular assays are highly amenable to automation and provide a suitable platform for routine application to the surveillance of HBV and HCV infections.


Copyright © Nucleus Global 2017. Part of Nucleus Global.
Design and Technology by Nucleus Global
Company registration No. 321 0712 (England & Wales). Registered Office address: Admiral House 76-78 Old Street, London EC1V 9AZ.